Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Murray

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Expert Opinion on Biological Therapy|December 10, 2008
CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37)Elizabeth A Mittendorf, Jarrod P Holmes, James L Murray, et al.
Cancer Treatment Reviews|March 17, 2004
Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issuesDaniel H Silverman, Ebrahim S Delpassand, Farzad Torabi, et al.
Expert Review of Vaccines|June 23, 2011
Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trialsElizabeth A Mittendorf, Gheath Alatrash, Haile Xiao, et al.
Virus Research|August 30, 2011
Host factors mediating HIV-1 replicationBrian M Friedrich, Natallia Dziuba, Guangyu Li, et al.
Journal of Cancer|August 29, 2013
Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized TrialNuhad K Ibrahim, James L Murray, Dapeng Zhou, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 2004
Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancerMichael E Gillogly, Nikoletta L Kallinteris, Minzhen Xu, et al.
Journal of Virology|February 16, 2007
Rab 5 is required for the cellular entry of dengue and West Nile virusesManoj N Krishnan, Bindu Sukumaran, Utpal Pal, et al.
The Journal of Biological Chemistry|September 6, 2003
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonistsJohn O Trent, Zi-xuan Wang, James L Murray, et al.
Cancer Research|April 5, 2005
Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or deathKouichiro Kawano, Clay L Efferson, George E Peoples, et al.
International Journal of Oncology|May 13, 2004
Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodesByung K Ko, Clay L Efferson, Kouichiro Kawano, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Expert Opinion on Biological Therapy|December 10, 2008
CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37)Elizabeth A Mittendorf, Jarrod P Holmes, James L Murray, et al.
Cancer Treatment Reviews|March 17, 2004
Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issuesDaniel H Silverman, Ebrahim S Delpassand, Farzad Torabi, et al.
Expert Review of Vaccines|June 23, 2011
Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trialsElizabeth A Mittendorf, Gheath Alatrash, Haile Xiao, et al.
Virus Research|August 30, 2011
Host factors mediating HIV-1 replicationBrian M Friedrich, Natallia Dziuba, Guangyu Li, et al.
Journal of Cancer|August 29, 2013
Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized TrialNuhad K Ibrahim, James L Murray, Dapeng Zhou, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 2004
Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancerMichael E Gillogly, Nikoletta L Kallinteris, Minzhen Xu, et al.
Journal of Virology|February 16, 2007
Rab 5 is required for the cellular entry of dengue and West Nile virusesManoj N Krishnan, Bindu Sukumaran, Utpal Pal, et al.
The Journal of Biological Chemistry|September 6, 2003
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonistsJohn O Trent, Zi-xuan Wang, James L Murray, et al.
Cancer Research|April 5, 2005
Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or deathKouichiro Kawano, Clay L Efferson, George E Peoples, et al.
International Journal of Oncology|May 13, 2004
Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodesByung K Ko, Clay L Efferson, Kouichiro Kawano, et al.
Pageof 7